Clinical Trial Update: Dostarlimab and Cobolimab in Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating dostarlimab plus cobolimab for advanced cervical cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cobolimab (cobolimab)
• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: Meghan Shea | Conditions: Cervical Cancer, Advanced Cervical Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING